STVNStevanato Group S.p.A.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Oversold (RSI 23). Price is +6% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A token position, settled Sep 15, 2026, about a week of normal trading to cover. Up 5.4% since the previous count, up from 0.3% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How STVN is trading
Stevanato Group S.p.A. is −27% over the past year while the S&P 500 is +18%: 46 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +5.9%
vs 200-day average · close to trend
- RSI (14)
- 23
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 30%
Below its 52-week high
Details›
- Last close2026-10-09
- $19.38
- 1 monthS&P 500 +2.7%
- −7.5%
- 1 yearS&P 500 +18%
- −27%
- 5 yearsS&P 500 +88%
- −27%
- vs 50-day average$20.99
- −7.7%
- 52-week high
- $27.51
- 52-week low
- $13.38
- Annualised volatility
- 49%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$562K
| Year | Return |
|---|---|
| 2026 (year to date) | −3.3% |
| 2025 | −7.4% |
| 2024 | −20% |
| 2023 | +52% |
| 2022 | −20% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | −3.3% |
| Feb | 5 | 2 of 5 | −2.0% |
| Mar | 5 | 3 of 5 | +7.9% |
| Apr | 5 | 3 of 5 | −1.00% |
| May | 5 | 4 of 5 | −1.8% |
| Jun | 5 | 2 of 5 | +3.7% |
| Jul | 5 | 4 of 5 | +5.6% |
| Aug | 6 | 4 of 6 | +4.6% |
| Sep | 6 | 3 of 6 | −0.31% |
| Oct | 6 | 1 of 6 | −3.3% |
| Nov | 5 | 1 of 5 | −4.7% |
| Dec | 5 | 3 of 5 | +2.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #4 of 21 by RyuScore